Oury Medical Acquires Cefimeca, Bolsters Medical Device Portfolio

Oury Medical, a prominent French industrial group focused on medical instrumentation, has significantly bolstered its capabilities by acquiring Cefimeca, a recognized French leader in orthopedic and spinal instruments and implants. This strategic move represents the fifth expansion under the platform strategy established by TAG Partners three years ago following their initial investment in Oury-Guye.

The transaction, designed to accelerate growth and technological advancement, was supported by a substantial funding round exceeding EUR 30 million. This capital infusion was provided by TAG Partners and ISALT, an independent French asset management firm, alongside a consortium of family offices and private investors. The funds will not only finance the acquisition but also strengthen Oury Medical's financial foundation for future investments in cutting-edge technology, expanded industrial capacity, and new growth initiatives.

Cefimeca brings over 25 years of specialized experience and a strong reputation for precision manufacturing in the orthopedic and spinal sectors. Operating from two production facilities in the Saint Etienne region, the company is particularly distinguished for its high-value implant range and its expertise in crafting complex surgical instruments. This acquisition integrates Cefimeca's specialized knowledge into Oury Medical's existing framework, enhancing the combined entity's offering.

The integration of Cefimeca positions the consolidated Oury Medical group as a formidable player, operating five production sites across France and employing over 200 professionals. This expanded footprint enables the company to offer a comprehensive 'One-Stop-Shop' solution for clients in the orthopedic and spinal surgery markets. The strategic objective is to solidify and expand its presence in key global markets for orthopedic and spinal procedures.

This development aligns perfectly with TAG Partners' long-term industrial vision. The firm has consistently pursued a buy-and-build strategy, with this being the fifth bolt-on acquisition aimed at constructing a robust and integrated medical instrumentation platform. The French medical device manufacturing sector, valued at approximately EUR 15 billion annually and experiencing steady growth driven by an aging population and advancements in surgical techniques, provides a fertile ground for such consolidation.

The combined entity is set to leverage synergies in manufacturing, research and development, and market access. By merging Oury Medical's established manufacturing prowess with Cefimeca's specialized implant and instrument expertise, the group is well-equipped to address the evolving demands of the global healthcare industry. This consolidation is expected to drive innovation and efficiency, ultimately benefiting patient care through improved surgical tools and implants.